Autres langues Abbott Laboratories

Actions

ABT

US0028241000

Equipement, fournitures et distribution médicale

Marché Fermé - NYSE 22:03:19 15/09/2026			Varia. 5j.	Varia. 1 janv.
102,03 ^USD	-1,03 %		-5,82 %	-18,56 %

15/09	Abbott annonce la première utilisation au Canada du système d'ablation par champ pulsé Volt pour traiter la fibrillation auriculaire	CI
14/09	Abbott Laboratories versera 385 millions de dollars pour clore le litige sur le lait maternisé	MT

Autres langues

15/09	Abbott Announces First Canadian Use of Volt Pulsed Field Ablation System to Treat Atrial Fibrillation
15/09	First Canadian Commercial Use of Abbott's Volt™ Pulsed Field Ablation System Advances Minimally Invasive Atrial Fibrillation Care
15/09	Abbott to pay $385M over infant formula contamination probe
14/09	Abbott agrees to settlement over closure of largest baby formula plant in the US
14/09	Abbott Laboratories to Pay $385 Million to Settle Infant Formula Allegations
14/09	Abbott to Pay $385 Million to Resolve Baby Formula Contamination Claims
14/09	Abbott to pay $384 million over contaminated infant formula allegations, US Justice Dept says
14/09	Abbott reaches agreement with Department of Justice to resolve claims relating to 2022 infant formula recall
08/09	Abbott Receives FDA Approval for Device to Treat Abnormal Heart Rhythm
08/09	Abbott Receives FDA Approval for TactiFlex Duo Ablation Catheter to Treat Abnormal Heart Rhythms
08/09	Abbott Laboratories Wins FDA Approval for Dual-Energy AFib Catheter
04/09	US companies face rise in cyber attacks
01/09	Mead Johnson wins US federal bellwether trial over preterm infant formula Enfamil
01/09	Medtronic Raises Full-Year Outlook Following Fiscal First-Quarter Beat
01/09	Oncology firm Novocure says cyberattack exposed US patient records
01/09	Reckitt shares rise after US jury backs unit Mead Johnson in baby formula case
01/09	Colorectal Cancer Alliance and Abbott Launch Online Hub Explaining Unexpected Home Delivery Of Colorectal Cancer Screening Kits
31/08	Abbott Launches Similac 360 Total Care Made with Whole Milk Ready-To-Feed Liquid Infant Formula in the United States
31/08	Abbott Laboratories : Late-breaking data for Abbott’s TactiFlex™ Duo Ablation Catheter reveal positive outcomes for treating complex AFib cases
31/08	Abbott Laboratories Introduces Similac 360 Total Care Made With Whole Milk in US
31/08	Abbott launches the first and only ready-to-feed liquid infant formula made with whole milk in the U.S. at similar price to its existing Similac powdered formula
31/08	Abbott Presents Positive 12-Month Outcomes for Tactiflex Duo Ablation Catheter in Treating Complex Afib Cases
27/08	Abbott Laboratories Insider Sold Shares Worth $46,204,798, According to a Recent SEC Filing
27/08	Abbott Laboratories' Stroke Treatment Device Receives CE Mark
27/08	Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke